Novavax Approval Process a Potential ‘Harbinger’ of Threat to FDA Integrity: Former Regulators

Writing in JAMA, four former governmental officials warn that the Trump administration’s involvement in delaying the approval of Novavax’s COVID-19 vaccine could indicate a politicization of the drug approval processes that could ‘imperil public health.’